Evidence-based clinical practice guidelines for chronic pancreatitis 2015

J Gastroenterol. 2016 Feb;51(2):85-92. doi: 10.1007/s00535-015-1149-x. Epub 2016 Jan 4.

Abstract

Chronic pancreatitis is considered to be an irreversible progressive chronic inflammatory disease. The etiology and pathology of chronic pancreatitis are complex; therefore, it is important to correctly understand the stage and pathology and provide appropriate treatment accordingly. The newly revised Clinical Practice Guidelines of Chronic Pancreatitis 2015 consist of four chapters, i.e., diagnosis, staging, treatment, and prognosis, and includes a total of 65 clinical questions. These guidelines have aimed at providing certain directions and clinically practical contents for the management of chronic pancreatitis, preferentially adopting clinically useful articles. These revised guidelines also refer to early chronic pancreatitis based on the Criteria for the Diagnosis of Chronic Pancreatitis 2009. They include such items as health insurance coverage of high-titer lipase preparations and extracorporeal shock wave lithotripsy, new antidiabetic drugs, and the definition of and treatment approach to pancreatic pseudocyst. The accuracy of these guidelines has been improved by examining and adopting new evidence obtained after the publication of the first edition.

Keywords: Chronis pancreatitis; Early stage chronic pancreatitis; GRADE system; Guidelines; Medical conservative therapy; Pain management; Pancreatic dysfunction; Pancreatic endocrine; Pancreatic exocrine; Surgical therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Evidence-Based Medicine / methods
  • Humans
  • Japan
  • Pain Management / methods
  • Pancreatitis, Chronic / diagnosis*
  • Pancreatitis, Chronic / pathology
  • Pancreatitis, Chronic / therapy*
  • Practice Guidelines as Topic*
  • Prognosis
  • Severity of Illness Index